Zenas Biopharma, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Zenas BioPharma, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on May 11, 2026, to elect directors and ratify its independent auditor.
NASDAQ
Zenas BioPharma announces its 2025 Annual Meeting of Stockholders to be held virtually on June 10, 2025, with key proposals including the election of directors and ratification of the company's accounting firm.
NASDAQ
Zenas BioPharma announces its 2025 Annual Meeting of Stockholders to be held virtually on June 10, 2025, featuring director elections and ratification of the company's auditor.